Erratum to “Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing” [Mater. Today Bio. 19 (2023) 100567]
Year: 2026
Type: erratum
Abstract: [This corrects the article DOI: 10.1016/j.mtbio.2023.100567.].
Source: Materials Today Bio
Institutions: Fox Chase Cancer Center, Temple University
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,400
OpenAlex ID: W7203622727
Cites:
Cited by:
Related to: